Routes of drug administration

From WikiLectures

We usually divide routes of drug administration that produce systemic effect in Enteral or Parenteral. From Greek Enteros = Intestine and Para = Beside. Thus either it passes through the intestinal tract or it avoids it. This is extremely important as some drugs are poorly absorbed in the intestines, others are well absorbed however are metabolized almost completely by first-pass effect.

Enteral[edit | edit source]

Are entering the intestinal tract.

Oral[edit | edit source]

Given by mouth is the most common route of drug administration, however it also the one with the most complicated pathway to the target tissues. Most drugs are absorbed in the intestinal tract by passive transfer and usually end up in the portal circulation encountering the liver and thus high chance of passing the first-pass effect.

Rectal[edit | edit source]

Rectal administration can be used for producing local or systemic effects. It is quite unreliable however. 75% of drainage of the rectal region bypasses the portal circulation and thus minimizing first-pass effect. The inferior and middle rectal veins are linked to the systemic circulation whereas the superior rectal vein joins the inferior mesentering vein and from there onto the portal vein. It can be very useful during vomiting and in patients that are unable to take medications by mouth.

Sublingual[edit | edit source]

Sublingual administration can be classified into Parenteral as well, it does not enter the lower GastroIntestinal Tract, however it is placed under the tongue thus going oral. The drug diffuses into the capillary network and enters the system circulation directly. It is very rapidly absorbed, low infection risk, avoiding the rough environment of the GIT and no first-pass metabolism.

Parenteral[edit | edit source]

This route of administration avoids the GIT, and is used for drugs that are poorly absorbed or unstable in the GIT, for unconscious patients and when acute onset is required.

Intravenous (IV)[edit | edit source]

Injection straight into the systemic circulation is the most common parenteral route. It is the fastest and most certain and controlled way. It bypasses absorption barriers and first-pass metabolism. It is used when a rapid effect is required, continuous administraction and large volumes. The disadvantages are that one cannot recall injected drugs, introduction of bacteria through contamination as well as too rapid delivery or too high concentration may produce strong adverse effects.

Intramuscular (IM)[edit | edit source]

Produces a faster effect than oral administration, however the rate of absorption depends greatly on the site of injection and on local blood flow. The drug can be aqueous solutions or depot preparations (in a form of ester or salt). The absorption of the aqueous is fast and the depot form is slow. The advantage of the depot form is that it can provide a sustained dose over an extend period of time.

Subcutaneous (SC)[edit | edit source]

The absoroption of subcutaneous injections is slower than that of IV route and it needs absorption similar to Intramuscular injection. However it minimizes the risks associated with IV injections.

Other routes[edit | edit source]

  • Inhalation

This route is used for gaseous drugs or those that can be dispersed in an aerosol, and is produces an effect almost as fast as with IV. It provides rapid delivery across the mucous membranes of the respirateory tract. It is used for asthmatic drugs, and anesthetics.

  • Intranasal

Drug administration directly into the nose. Includes agents such as nasal decongestants or cocaine by abusers.

  • Topical

As the name implies, it is applied where and when a local effect of the drug is desired.

  • Transdermal

Drug administration through the skin. It can achieve systemic effects but rate of absorption can vary markedly depending on the physical characteristics of the skin at application.

  • Intrathecal / Intravetricular

Drug administration into the cerebrospinal fluid (CSF). Used in cases of CNS cancers, cryptococcal meningitis etc.

Links[edit | edit source]

Related articles[edit | edit source]

Bibliography[edit | edit source]

  • FINKEL, CLARK, CUBEDDU, HARVEY, CHAMPE,, et al. Lippincott's Illustrated Reviews: Pharmacology. 4. edition. 2009. ISBN 978-1605472003.
  • HUMPHREY, RANG, DALE, RITTER, FLOWER, HENDERSON,, et al. Rang and Dale's Pharmacology. 7. edition. 2007. ISBN 978-0702034718.